EU Commission Approval of Tibsovo® (Ivosidenib) in IDH1-mutated Cholangiocarcinoma
The European Commission approved the use of Tibsovo® (Ivosidenib) as monotherapy for the treatment of locally advanced or metastatic cholangiocarc...
Collaboration with COR2ED – HCC CONNECT
DiCE is pleased to collaborate with HCC CONNECT. HCC CONNECT is an international group of experts in hepatocellular carcinoma (HCC).
...Liver Cancer Index – Data Gaps
DiCE has started disseminating a survey this spring among clinicians, public health experts, and patient advocates to help to sketch the landscape ...
Highlights from the EASL Liver Cancer Summit
The European Association for the Study of the Liver (EASL) held the Liver Cancer Summit, its annual conference focused on liver cancer in Estoril, ...